MERCK KGAA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.2 EUR | -0.62% |
|
-1.79% | +4.72% |
| 03:42pm | Merck KGaA Rolls Out New Genetic Stability Assay Platform | MT |
| Apr. 13 | MERCK : A peer group tidy up |  |
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, welcome to the Merck Inv...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
Pharmaceuticals
Calendar
2024-04-25
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
152.2
EUR
Average target price
182
EUR
Spread / Average Target
+19.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.72% | 70.36B | |
| +12.11% | 9.26B | |
| -16.73% | 4.72B | |
| +23.84% | 3.89B | |
| +1.45% | 3.75B | |
| +30.75% | 2.66B | |
| -24.17% | 2.37B | |
| -27.04% | 2.17B | |
| -3.78% | 1.75B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Transcript : MERCK Kommanditgesellschaft auf Aktien, Q3 2022 Earnings Call, Nov 10, 2022
